Merck's great dilemma: promote their old drug Ivermectin for which they will receive 0 dollars, or their new untried anti-viral for which they'll receive > US$1bn?
Merck's great dilemma: promote their old drug Ivermectin for which they will receive 0 dollars, or their new untried anti-viral for which they'll receive > US$1bn?
Merck's great dilemma: promote their old drug Ivermectin for which they will receive 0 dollars, or their new untried anti-viral for which they'll receive > US$1bn?